Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Maze Therapeutics Inc.

    NASDAQ: MAZE · Real-Time Price · USD
    12.87
    -0.47 (-3.52%)
    At close: Jun 06, 2025, 3:59 PM
    12.59
    -2.18%
    After-hours: Jun 06, 2025, 05:57 PM EDT

    Maze Therapeutics Statistics

    Share Statistics

    Maze Therapeutics has 43.8M shares outstanding. The number of shares has increased by null% in one year.

    Shares Outstanding

    n/a
    		 43.8M

    Shares Change (YoY)

    n/a
    		 n/a

    Shares Change (QoQ)

    n/a
    		 n/a

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 14,809

    FTD / Avg. Volume

    n/a
    		 6.7%

    Short Selling Information

    The latest short interest is 2.03M, so 4.63% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 2.03M

    Short % of Shares Out

    n/a
    		 4.63%

    Short % of Float

    n/a
    		 5.66%

    Short Ratio (days to cover)

    n/a
    		 15.58

    Valuation Ratios

    The PE ratio is 13.37 and the forward PE ratio is -4.02. Maze Therapeutics's PEG ratio is -0.13.

    PE Ratio

    n/a
    		 13.37

    Forward PE

    n/a
    		 -4.02

    PS Ratio

    n/a
    		 4.17

    Forward PS

    n/a
    		 6.5

    PB Ratio

    n/a
    		 -2.24

    P/FCF Ratio

    n/a
    		 9.33

    PEG Ratio

    n/a
    		 -0.13
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Maze Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 9.76, with a Debt / Equity ratio of -0.09.

    Current Ratio

    n/a
    		 9.76

    Quick Ratio

    n/a
    		 9.76

    Debt / Equity

    n/a
    		 -0.09

    Debt / EBITDA

    n/a
    		 0.44

    Debt / FCF

    n/a
    		 0.36

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $1,340,000

    Profits Per Employee

    n/a
    		 $417,848

    Employee Count

    n/a
    		 125

    Asset Turnover

    n/a
    		 0.7

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 1.17M

    Effective Tax Rate

    n/a
    		 2.19%

    Stock Price Statistics

    The stock price has increased by null% in the last 52 weeks. The beta is 1.85, so Maze Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.85

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 9.87

    200-Day Moving Average

    n/a
    		 n/a

    Relative Strength Index (RSI)

    n/a
    		 62.97

    Average Volume (20 Days)

    n/a
    		 221,153

    Income Statement

    In the last 12 months, Maze Therapeutics had revenue of 167.5M and earned 52.23M in profits. Earnings per share was 0.08.

    Revenue

    n/a
    		 167.5M

    Gross Profit

    n/a
    		 167.5M

    Operating Income

    n/a
    		 57.59M

    Net Income

    n/a
    		 52.23M

    EBITDA

    n/a
    		 60.88M

    EBIT

    n/a
    		 57.59M

    Earnings Per Share (EPS)

    n/a
    		 0.08
    Full Income Statement

    Balance Sheet

    The company has 196.81M in cash and 26.63M in debt, giving a net cash position of 170.18M.

    Cash & Cash Equivalents

    n/a
    		 196.81M

    Total Debt

    n/a
    		 26.63M

    Net Cash

    n/a
    		 170.18M

    Retained Earnings

    n/a
    		 -358.43M

    Total Assets

    n/a
    		 332.84M

    Working Capital

    n/a
    		 281.09M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 75.95M and capital expenditures -1.15M, giving a free cash flow of 74.81M.

    Operating Cash Flow

    n/a
    		 75.95M

    Capital Expenditures

    n/a
    		 -1.15M

    Free Cash Flow

    n/a
    		 74.81M

    FCF Per Share

    n/a
    		 1.71
    Full Cash Flow Statement

    Margins

    Gross margin is 100%, with operating and profit margins of 34.38% and 31.18%.

    Gross Margin

    n/a
    		 100%

    Operating Margin

    n/a
    		 34.38%

    Pretax Margin

    n/a
    		 31.88%

    Profit Margin

    n/a
    		 31.18%

    EBITDA Margin

    n/a
    		 36.35%

    EBIT Margin

    n/a
    		 34.38%

    FCF Margin

    n/a
    		 44.66%

    Dividends & Yields

    MAZE does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for MAZE is $28, which is 111% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $28

    Price Target Difference

    n/a
    		 111%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 3
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 5.62

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist